July 17, 2024 08:00 AM EDT

AI drug development company gets $80M backing from Pfizer, Nvidia and Thermo Fisher

Ayisha Sharma

News Reporter

Pfizer, Nvidia and Thermo Fisher have pitched in to help a machine learning firm amplify its AI approach, which could help biopharma companies better succeed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AI drug development company gets $80M backing from Pfizer, Nvidia and Thermo Fisher

Ayisha Sharma

News Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

AI drug de­vel­op­ment com­pa­ny gets $80M back­ing from Pfiz­er, Nvidia and Ther­mo Fish­er

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

AI drug development company gets $80M backing from Pfizer, Nvidia and Thermo Fisher